2nd HFpEF & HCM Drug Discovery & Development Summit
24
Jan
-
26
Jan
2023
When
Boston

USA
Where

Welcome to the 2nd HFpEF & HCM Drug Discovery & Development Summit The Industry's Only Definitive Forum for Cardiovascular Drug Discovery & Development Cardiovascular stakeholders are racing to answer the burning questions limiting them from capitalizing on their commercial success.

Similar Events

You May Like

event-img
(0)
31 January-01 February 2023
Health Benefits Conference & Expo 2023
event-img
event-img
(0)
31 January-02 February 2023
3rd annual Fermentation-Enabled Alternative Protein Summit
event-img
event-img
(0)
31 January-02 February 2023
7th Microbiome Movement - Drug Development Summit Europe
event-img
event-img
(0)
05-09 February 2023
AGBT General Meeting
event-img
event-img
(0)
07-09 February 2023
16th Edition Pharmaceutical Resource Planning And Portfolio Management
event-img
event-img
(0)
08-09 February 2023
Healthcare Payment & Revenue Integrity Summit
event-img
event-img
(0)
08-09 February 2023
Connected Health & Fitness Summit
event-img
event-img
(0)
09-09 February 2023
Digital Health Nordic
event-img
event-img
(0)
09-10 February 2023
Neuroscience and Brain Disorder
event-img
event-img
(0)
13-15 February 2023
Canadian Health And Wellness Innovations
event-img

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

24 - 26 Jan 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Postdoctoral Fellow
Vice President - Worldwide Research & Development
Senior Director & Head of Precision Cardiology Laboratory
Executive Vice President
Vice President - Global Translational Medicine & Head of Cardiovascular & Metabolism
Chief Medical Officer
Chief Scientific Officer
Global Clinical Leader
Founder and CSO
Senior Scientist
Chief Medical Officer & SVP, Clinical Development
Executive Director - Diabetes & Cardiovascular

Sponsors and Exhibitors
Brand, Media and Promotional Partners

AnaBios Corporation

AnaBios generates highly valuable, predictive human data in advance of clinical trials, ensuring the selection of the most effective and safest drugs, thereby reducing the time and expense related to clinical trial failures.

Antaros Medical

Visualizing the Future – Minimizing risk Antaros Medical is an entirely unique service provider. We are pioneering new frontiers in innovative MRI/PET imaging techniques, seamless clinical drug development and understanding of human pathophysiology.

Nordic Bioscience A/S

Nordic Bioscience is the leading expert in extracellular matrix (ECM) research with 25+ years of experience in biomarker development, pre-clinical and clinical research.

OM1, Inc.

OM1 is a leading health outcomes and registries company focused on the measurement, comparison, and prediction of treatment outcomes.

Physiogenex

Physiogenex is a leading preclinical contract research organization (CRO) specializing in metabolic disorders such as diabetes, obesity, liver diseases, dyslipidemia, atherosclerosis and cardiovascular complications.

Organizer

Get emails from us

 
Thank you
Oops! Something went wrong